Ratings by Deutsche Bank (James Shin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | Ascentage Pharma Group | AAPG | New Coverage | Buy (N/A) |
25.13 (18.50) |
-26.38% | Details | |
| 3/27/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | Merck | MRK | Upgrade | Buy (Hold) |
119.24 (129.56) |
8.65% | Details | |
| 2/11/2026 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 2/11/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2026 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2025 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2025 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 11/11/2025 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 11/5/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 9/15/2025 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 7/29/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | Immatics | IMTX | New Coverage | Buy (N/A) |
5.11 (9.95) |
94.72% | Details | |
| 5/27/2025 | Immunocore Holdings | IMCR | New Coverage | Buy (N/A) |
31.21 (32.50) |
4.13% | Details | |
| 2/26/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2025 | Gilead Sciences | GILD | Upgrade | Buy (Hold) |
104.08 (131.27) |
26.12% | Details | |
| 2/18/2025 | Merck | MRK | Downgrade | Hold (Buy) |
83.01 (129.56) |
56.08% | Details | |
| 2/10/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 12/11/2024 | Gilead Sciences | GILD | Maintain | Hold (N/A) |
|
Details | ||
| 11/4/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 10/3/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2024 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 9/6/2024 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 9/3/2024 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 8/27/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | Eli Lilly | LLY | Upgrade | Buy (Hold) |
891.68 (1213.91) |
36.14% | Details | |
| 7/23/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 7/17/2024 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 5/24/2024 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 5/23/2024 | Legend Biotech Corp. | LEGN | New Coverage | Buy (N/A) |
42.60 (29.91) |
-29.79% | Details | |
| 5/23/2024 | Incyte | INCY | New Coverage | Hold (N/A) |
58.20 (116.86) |
100.79% | Details | |
| 5/14/2024 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 4/5/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2024 | Eli Lilly | LLY | Maintain | Hold (N/A) |
|
Details | ||
| 2/8/2024 | Eli Lilly | LLY | Maintain | Hold (N/A) |
|
Details | ||
| 2/5/2024 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 2/2/2024 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2024 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2024 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 11/30/2023 | Immunogen Inc. | IMGN | Downgrade | Hold (Buy) |
16.06 (31.25) |
94.58% | Details | |
| 11/20/2023 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 11/9/2023 | Immunogen Inc. | IMGN | New Coverage | Buy (N/A) |
15.98 (31.25) |
95.56% | Details | |
| 11/9/2023 | Merck | MRK | New Coverage | Buy (N/A) |
104.00 (129.56) |
24.58% | Details | |
| 11/9/2023 | Gilead Sciences | GILD | New Coverage | Hold (N/A) |
80.61 (131.27) |
62.85% | Details | |
| 11/9/2023 | Bristol-Myers Squibb Co. | BMY | New Coverage | Hold (N/A) |
52.29 (58.13) |
11.17% | Details | |
| 11/9/2023 | Autolus Therapeutics plc | AUTL | New Coverage | Buy (N/A) |
3.68 (1.58) |
-57.07% | Details | |
| 11/9/2023 | Eli Lilly | LLY | New Coverage | Hold (N/A) |
599.93 (1213.91) |
102.34% | Details | |
| 11/9/2023 | Abbvie | ABBV | New Coverage | Hold (N/A) |
142.16 (261.07) |
83.65% | Details | |
| 11/9/2023 | Sutro Biopharma | STRO | New Coverage | Buy (N/A) |
2.62 (30.43) |
1061.45% | Details | |
| 11/9/2023 | Regeneron Pharma | REGN | New Coverage | Hold (N/A) |
830.79 (654.27) |
-21.25% | Details | |
| 11/9/2023 | Amgen | AMGN | New Coverage | Hold (N/A) |
271.11 (374.15) |
38.01% | Details |
